ALNY vs WDAY · P/E 76, rev $1.29B vs P/E 135, rev $5.19B
Alnylam Pharmaceuticals Inc (ALNY) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the ALNY and WDAY stock pages for the full models.
Not investment advice.